The design of prophylactic trials for HIV: the case of microbicides.
Stein
Zena A
ZA
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, USA. sengupt@sergievsky.cpmc.columbia.edu
Myer
Landon
L
Susser
Mervyn
M
D000282:Administration, Intravaginal; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage*; D019111:Single-Use Internal Condom; D005260:Female; D006678:HIV / Q000187:drug effects; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission / Q000821:virology; D006801:Humans; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D015229:Sexually Transmitted Diseases, Viral / Q000517:prevention & control; D014481:United States; D014622:Vaginal Creams, Foams, and Jellies
D000891:Anti-Infective Agents, Local; D010919:Placebos; D014622:Vaginal Creams, Foams, and Jellies